Outcome after radioidine therapy in pacients with Grave's disease
PDF (English)

Palavras-chave

Hyperthyroidism
Graves disease
Radioiodine theraphy.

Como Citar

OKUMA, Isabela Sayuri; WITTMANN, Denise Engelbrecht Zantut; LIMA, Isabella Lucca de Campos; NETO, Arnaldo Moura; TAMBASCIA, Marcos Antonio; RAMOS, Celso Dario. Outcome after radioidine therapy in pacients with Grave’s disease: interrelation between demographycs and disorders properties. Revista dos Trabalhos de Iniciação Científica da UNICAMP, Campinas, SP, n. 26, 2019. DOI: 10.20396/revpibic262018626. Disponível em: https://econtents.bc.unicamp.br/eventos/index.php/pibic/article/view/626. Acesso em: 11 maio. 2024.

Resumo

Graves disease is an autoimmune condition and the main cause of hyperthyroidism. The present study consists of the analysis of the evolution after radioidine theraphy treatment in pacients with Graves' disease, wich took place at the Thyroid Dysfunction Unit of Endocrinology Division, HC-Unicamp, according to its pacients charts review. Radioidine theraphy (RIT) was indicated in 68% of the pacients (171/251), of whom 80,1% (n=137) of these cases after RIT presented definitive control of the disease with one radioidine admnistration. Therefore, the outcome of the patient related to the RIT failure was the thyroid volume according to the ultrasound and the scintigraphy uptake, and in addition, the thyroid volume was reported as a predictor factor for the failure to control hyperthyroidism.

https://doi.org/10.20396/revpibic262018626
PDF (English)

Todos os trabalhos são de acesso livre, sendo que a detenção dos direitos concedidos aos trabalhos são de propriedade da Revista dos Trabalhos de Iniciação Científica da UNICAMP.

Downloads

Não há dados estatísticos.